COVID-19
As a little girl, Tamika Felder dreamed of being on TV. She loved watching the news even at a very young age, had an unwavering curiosity about what was going on in the world, and set her sights on a career in television, which she later achieved. What she didn’t set her sights on was a cervical cancer diagnosis at the age of 25, a radical hysterectomy, and the devastating complete loss of her fertility.
With concerted efforts by navigators, we can increase preventive screening rates.
As we begin to move forward from the COVID-19 pandemic, there are long-term consequences of the delay in cancer screenings that need to be addressed immediately.
Oncology navigators can help their patients feel comfortable to come in for cancer screenings by educating them and empowering them with the knowledge they need to make informed decisions.
Hospitals and medical providers are following safety and cleaning guidelines and considering capacity to minimize risk of COVID-19 for patients.
Andi Dwyer, BS, shares how hesitancy around cancer screenings during COVID-19 could lead to a rise in cancer cases.
Patients who delayed their cancer screenings due to the pandemic are now joining patients who were scheduled for screenings in 2021, leading to a large patient volume for institutions to consider.
Andi Dwyer, BS, explains how the COVID-19 pandemic delayed many cancer screenings for the average-risk population.
Christian Downs, JD, MHA, Linda Fleisher, PhD, MPH, Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG, Mandi Pratt-Chapman, MA, PhD, HON-OPN-CG, Rani Khetarpal, MBA
Leaders from the Academy of Oncology Nurse & Patient Navigators deliver a statement on appropriate planning to serve patients and their families in the wake of the COVID-19 pandemic.
When outpatient visits increased from 0 to 2156 by the end of September 2020, a comprehensive cancer center had to transition quickly. Here’s what they learned.
© 2009-2023 DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512